John Bingham Selected Research

Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)

1/2011

Increased inducible nitric oxide synthase expression in organs is associated with a higher severity of H5N1 influenza virus infection.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

John Bingham Research Topics

Disease

17	Infections 01/2022 - 03/2007
6	Rabies (Hydrophobia) 01/2022 - 03/2002
4	Influenza in Birds (Avian Flu) 01/2018 - 03/2007
3	Neoplasms (Cancer) 01/2023 - 04/2011
3	Henipavirus Infections 10/2009 - 12/2006
2	COVID-19 01/2022 - 05/2021
2	Human Influenza (Influenza) 01/2018 - 04/2011
2	Virus Diseases (Viral Diseases) 11/2011 - 08/2007
1	Lymphoma (Lymphomas) 01/2023
1	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2023
1	Newcastle Disease 01/2017
1	African Swine Fever 01/2017
1	Viremia 01/2016
1	Cytokine Release Syndrome 06/2014
1	Paralysis (Palsy) 06/2014
1	Meningoencephalitis 06/2014
1	Seizures (Absence Seizure) 06/2014
1	Pain (Aches) 04/2014
1	Chronic Pain 04/2014
1	Inflammation (Inflammations) 01/2011
1	Fever (Fevers) 01/2008
1	Urinary Bladder Neoplasms (Bladder Cancer) 10/2007
1	Infarction (Infarctions) 06/2003
1	Lumpy Skin Disease 06/2002

Drug/Important Bio-Agent (IBA)

5	VaccinesIBA 01/2022 - 06/2002
5	AntigensIBA 01/2018 - 03/2002
4	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2010
3	CytokinesIBA 06/2014 - 01/2011
2	Antiviral Agents (Antivirals)IBA 01/2022 - 01/2016
2	Messenger RNA (mRNA)IBA 01/2020 - 01/2014
2	Acute-Phase Proteins (Acute-Phase Protein)IBA 06/2014 - 01/2011
2	Neutralizing AntibodiesIBA 10/2009 - 01/2008
1	loncastuximab tesirineIBA 01/2023
1	pyrrolo(2,1-c)(1,4)benzodiazepineIBA 01/2023
1	DNA (Deoxyribonucleic Acid)IBA 01/2023
1	Immunoconjugates (Immunoconjugate)IBA 01/2023
1	IminesIBA 01/2023
1	NucleoproteinsIBA 01/2022
1	ChAdOx1 nCoV-19IBA 05/2021
1	MicroRNAs (MicroRNA)IBA 01/2021
1	Indicators and Reagents (Reagents)IBA 07/2020
1	Chemokine CXCL10IBA 01/2020
1	ChemokinesIBA 01/2020
1	Basic Amino Acids (Basic Amino Acid)IBA 01/2018
1	Hemagglutinins (Hemagglutinin)IBA 01/2018
1	AcetoneIBA 11/2017
1	Formaldehyde (Formol)FDA Link 11/2017
1	RNA (Ribonucleic Acid)IBA 01/2017
1	AerosolsIBA 11/2015
1	Interleukin-6 (Interleukin 6)IBA 06/2014
1	A-factor (Streptomyces)IBA 06/2014
1	Serum Amyloid A Protein (Serum Amyloid A)IBA 06/2014
1	LigandsIBA 01/2014
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2014
1	AntibodiesIBA 07/2012
1	RestonIBA 11/2011
1	InterleukinsIBA 04/2011
1	Interleukin-4 (Interleukin 4)IBA 04/2011
1	Interleukin-10 (Interleukin 10)IBA 04/2011
1	Interleukin-12 (IL 12)IBA 04/2011
1	InterferonsIBA 04/2011
1	Nitric Oxide Synthase (NO Synthase)IBA 01/2011
1	EnzymesIBA 01/2011
1	Oxidants (Oxidizing Agents)IBA 01/2011
1	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 01/2011
1	Monoclonal AntibodiesIBA 10/2009
1	ElementsIBA 09/2007
1	Caspase 3 (Caspase-3)IBA 08/2007
1	CaspasesIBA 08/2007
1	Caspase 9IBA 08/2007
1	Caspase 8 (Caspase-8)IBA 08/2007
1	Inactivated VaccinesIBA 03/2007
1	Subunit VaccinesIBA 12/2006
1	Glycoproteins (Glycoprotein)IBA 12/2006
1	Lysergic Acid Diethylamide (LSD)IBA 06/2002
1	Synthetic Vaccines (Recombinant Vaccines)IBA 06/2002

Therapy/Procedure

3	Therapeutics 01/2022 - 04/2014
1	Critical Care (Surgical Intensive Care) 01/2022
1	Investigational Therapies (Experimental Therapy) 01/2022
1	Proton Therapy 03/2016
1	Sensory Art Therapies 04/2014
1	Drug Therapy (Chemotherapy) 04/2011
1	Cystectomy 10/2007
1	Renal Dialysis (Hemodialysis) 06/2003